Disciplined Execution,
Globally Delivered

Michael Zhang is the Founder & CEO of Luminark Holdings, with more than 35 years of experience in corporate operations, industrial resource integration, and U.S. capital markets project execution. He has long been deeply engaged in the electronics industry, global supply chains, professional service networks, healthcare-related services, and artificial intelligence infrastructure. He is skilled at building enterprise platforms with financing capability and expansion potential by systematically advancing opportunities from industrial opportunity assessment, project structure design, and team organization to capital markets pathway execution.

Since 2015, Michael has continuously participated in U.S. public market-related projects, with a focus on sponsor-side structure design, corporate governance, transaction preparation, and listed-platform development. His practical experience in cross-border capital markets project organization and public market execution spans the full lifecycle from sponsor formation through NYSE listing and post-close operations.

As the Founder and CEO of Luminark Holdings, Michael leads the company's systematic layout across direct investment, AI infrastructure, healthcare innovation, premium service networks, and future public market opportunities. He is committed to transforming early-stage opportunities with real industrial foundations into enterprise platforms that are governable, financeable, scalable, and capable of creating capital markets value.

Dr. Loretta Pratt is a dual board-certified physician in dermatology and internal medicine, bringing a highly specialized medical background to the evaluation of aesthetic medicine, skin health, laser technologies, and physician-guided beauty and wellness platforms.

In the United States, board certification in dermatology represents one of the most rigorous standards in skin medicine. Dr. Pratt's additional board certification in internal medicine gives her a broader clinical perspective on patient health, treatment suitability, safety, and long-term outcomes. This rare combination allows her to evaluate aesthetic and wellness opportunities not only from a beauty or market perspective, but through a disciplined medical and clinical lens.

At Luminark Holdings, Dr. Pratt serves as Principal Medical Aesthetics Advisor, providing strategic guidance on medical aesthetics, dermatology-related opportunities, laser and energy-based aesthetic technologies, physician-led service models, clinical safety standards, treatment protocol evaluation, and healthcare investment opportunities in beauty, wellness, and advanced aesthetic technologies.

Kenny Zeng is a technology executive, entrepreneur, and investment strategist with more than 15 years of practical experience across technology ventures, corporate operations, digital commerce, intelligent hardware, and China-based supply chain ecosystems.

Kenny has a background involving CTO-level responsibilities and previously worked at Motorola, giving him a practical foundation in technology development, product execution, corporate management, and scalable business operations. Over the course of his career, he has invested in, founded, and operated multiple companies across e-commerce, brand development, digital platforms, and emerging technology sectors.

At Luminark Holdings, Kenny supports the firm's strategic initiatives in AI, robotics, intelligent hardware, and technology investment. His core role includes evaluating emerging technology opportunities, identifying investable business models, connecting strategic manufacturing and supply chain resources, facilitating China-U.S. technology collaboration, and helping transform high-potential technology concepts into executable and commercially viable ventures.